This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters To the Editor

Ribavirin May Be an Important Factor in IFN-Induced Neuropsychiatric Effects

Gregory M. Asnis MD, Richard De La Garza II PhD, Andrew H. Miller MD, and Charles L. Raison MD

Published: April 1, 2004

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: The recent article by Kraus et al.1 is of considerable interest since interferon (IFN)-induced neuropsychiatric effects are highly prevalent, but minimally studied, in prospectively designed reports. As reported previously, IFN treatment of chronic hepatitis C resulted in a significant increase in depression, anxiety, and irritability/hostility scores. These neuropsychiatric disturbances frequently necessitate dose reduction and/ or treatment discontinuation, an approach that may compromise the treatment of hepatitis C virus (HCV).

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 65

Quick Links: Neurologic and Neurocognitive , Neurology

Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...